AppointmentsConservative MP Dr Dan Poulter Joins UK Cannabis Company’s...

Conservative MP Dr Dan Poulter Joins UK Cannabis Company’s Board Of Directors


MEDICAL cannabis company Kanabo Group has appointed Dr Dan Poulter MP as a Non-Executive Director to the board.

Dr Poulter, a former UK Government health minister, and chairperson of the All-Party Parliamentary Group for Global Health, has in-depth knowledge of the drugs and medicines regulatory framework in the UK. 

A practicing NHS Psychiatrist, he believes that prescribed cannabis products could bring considerable health benefits to help people experiencing mental ill health and distress. 

Dr Poulter

Dr Poulter said: “As a doctor, I am increasingly aware of the potential of cannabis-based medicines. Cannabis products are fast becoming available that could deliver significant improvements to the lives of thousands of patients suffering from conditions ranging from chronic pain to post traumatic stress disorder.”

Avihu Tamir, CEO, Kanabo Group, said: “We are delighted to welcome Dr Dan Poulter, MP as a Non-Executive Director to our board. Dan brings a wealth of knowledge and insight into the business that strengthens our team as we build a medicinal cannabis market in the UK and Europe.” 

 Chairman of the Board, David Tsur, added: “We are delighted that Dr Dan Poulter has joined us and we’d like to warmly welcome him. He brings a wealth of experience and I’m sure will be a very valuable addition to the board. It’s an exciting period for Kanabo to execute the company’s business plan and to expand its activity and strategic partnerships.”

Peter McCusker is an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant.

Latest news

MGC Pharmaceuticals Releases Update On CimetrA Clinical Trial Progress In USA

MGC Pharmaceuticals Ltd (ASX, LSE: MXC, ‘MGC Pharma’ or ‘the Company’), a European based bio-pharma company specialising in the production and development...

European Cannabis Stocks Review: Akanda’s ‘Concerned Shareholders’ Oust All Directors Except CEO To Prevent ‘Potentially Irreparable Harm’ – More From Goodbody Health & Chill...

It has been another week of positive developments for the cannabis industry across Europe, with yet more markets making...

Analysis Shows UK Market Could Grow To Over £1bn By 2026 As London Prepares To Host Europe’s Leading Cannabis Conference

ANALYSIS shows UK market could grow to over £1bn by 2026 as London prepares to host Europe’s leading cannabis...

Medical Cannabis Could Be Available In Spain By The End Of The Year

SPAIN could now see the regulation and distribution of medical cannabis rolled out before the end of the year...

New UK Company Heralds Its ‘Unique’ Medical Cannabis Delivery Mechanism

CANNABIS extraction and formulations specialist 113 Botanicals is in the process of securing Good manufacturing Practice (GMP) compliance for...

German Cannabis Bill By Year End With Adult-Use Launch Likely In Early 2024

GERMANY’s draft cannabis law should be ready by the end of the year with the launch of its adult-use...

Must read

You might also likeRELATED
Recommended to you